AU2022901577A0 - Methods and compositions for enhancing partial reprogramming - Google Patents

Methods and compositions for enhancing partial reprogramming

Info

Publication number
AU2022901577A0
AU2022901577A0 AU2022901577A AU2022901577A AU2022901577A0 AU 2022901577 A0 AU2022901577 A0 AU 2022901577A0 AU 2022901577 A AU2022901577 A AU 2022901577A AU 2022901577 A AU2022901577 A AU 2022901577A AU 2022901577 A0 AU2022901577 A0 AU 2022901577A0
Authority
AU
Australia
Prior art keywords
compositions
methods
partial reprogramming
enhancing
enhancing partial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022901577A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mesoblast International SARL
Original Assignee
Mesoblast International SARL
Filing date
Publication date
Application filed by Mesoblast International SARL filed Critical Mesoblast International SARL
Publication of AU2022901577A0 publication Critical patent/AU2022901577A0/en
Priority to PCT/IB2023/055908 priority Critical patent/WO2023238074A1/en
Pending legal-status Critical Current

Links

AU2022901577A 2022-06-08 2022-06-08 Methods and compositions for enhancing partial reprogramming Pending AU2022901577A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/IB2023/055908 WO2023238074A1 (en) 2022-06-08 2023-06-08 Mesenchymal progenitor cells for enhancing partial reprogramming of target cells

Publications (1)

Publication Number Publication Date
AU2022901577A0 true AU2022901577A0 (en) 2022-06-23

Family

ID=

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023238074A1 (en) 2022-06-08 2023-12-14 Mesoblast International Sarl Mesenchymal progenitor cells for enhancing partial reprogramming of target cells

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023238074A1 (en) 2022-06-08 2023-12-14 Mesoblast International Sarl Mesenchymal progenitor cells for enhancing partial reprogramming of target cells

Similar Documents

Publication Publication Date Title
EP4121522A4 (en) Methods and compositions for directed genome editing
EP3952914A4 (en) Methods and compositions for targeted protein degradation
EP4136254A4 (en) Ace2-targeted compositions and methods for treating covid-19
EP3931336A4 (en) Compositions and methods for treating laminopathies
EP4006054A4 (en) Method and composition for anti-cd73 antibodies and variants
EP4096675A4 (en) Compositions and methods for treating long covid
EP4045094A4 (en) Compositions and methods for treating liver disease
EP3937882A4 (en) Compositions and methods for promoting mineralization
EP4138879A4 (en) Methods and compositions
EP4084784A4 (en) Compositions and methods
EP3976767A4 (en) Compositions and methods for cellular reprogramming
EP4114176A4 (en) Sterilization compositions and methods for using thereof
EP4021467A4 (en) Compositions comprising bacterial species and methods related thereto
AU2022344251A1 (en) Serpina-modulating compositions and methods
EP4149450A4 (en) Compositions and methods for hardening
AU2022901577A0 (en) Methods and compositions for enhancing partial reprogramming
EP4048310A4 (en) Compositions and methods for minimizing protein loss at low protein concentrations
EP4069253A4 (en) Method and compositions for treating glioblastoma
AU2020407501A1 (en) Methods and compositions for evaluating and treating fibrosis
AU2020327592A1 (en) Sprayable composition and method
AU2023903449A0 (en) Tau-binding proteins and related compositions and methods
AU2023901845A0 (en) Methods and compositions
AU2023900291A0 (en) Methods and compositions
AU2022901603A0 (en) Methods and compositions
AU2021902896A0 (en) Method and Composition